𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rationale of regional chemotherapy for melanoma metastatic to the liver

✍ Scribed by H. Voigt

Book ID
112785810
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
126 KB
Volume
111
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale for using TNFΞ± and chemotherap
Rationale for using TNFΞ± and chemotherapy in regional therapy of melanoma
✍ F. Lejeune; D. LiΓ©nard; A. Eggermont; H. Schraffordt Koops; F. Rosenkaimer; J. G πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 950 KB

Recombinant tumor necrosis factor-alpha (rTNFa) has potent antitumor activity in experimental studies on human tumor xenografts. However, in humans, the administration of rTNFa is hampered by severe systemic side-effects. The maximum tolerated dose ranges from 350 to 500 mg/m2, which is at least 1 O

Systemic chemotherapy for the treatment
Systemic chemotherapy for the treatment of metastatic melanoma
✍ Yan Li; Edward F McClay πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 English βš– 118 KB

The role of systemic chemotherapy in the treatment of patients with metastatic melanoma remains of questionable benefit. Despite encouraging phase II data from multiple institutions that suggested an improved overall response rate for patients treated with the Dartmouth regimen, recently completed p